Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Marketable Securities: €61.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E9Q Guangdong Kanghua Healthcare Group Co Ltd FRA:E9Q
82 GF Score
Price €0.17
GF Value €0.20
! 1 Warning Sign
View Full Analysis

What is Guangdong Kanghua Healthcare Group Co Marketable Securities?

Guangdong Kanghua Healthcare Group Co FRA:E9Q 82 Marketable Securities is €61.8 Mil as of Dec. 2025. GuruFocus rates FRA:E9Q with a GF Score™ of 82/100 and a GF Value™ of €0.20. The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Guangdong Kanghua Healthcare Group Co's Marketable Securities for the quarter that ended in Dec. 2025 was €61.8 Mil.

Guangdong Kanghua Healthcare Group Co's annual Marketable Securities increased from Dec. 2023 (€53.1 Mil) to Dec. 2024 (€57.2 Mil) and increased from Dec. 2024 (€57.2 Mil) to Dec. 2025 (€61.8 Mil).

Guangdong Kanghua Healthcare Group Co  (FRA:E9Q) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Guangdong Kanghua Healthcare Group Co Marketable Securities Related Terms

Guangdong Kanghua Healthcare Group Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Guangdong Kanghua Healthcare Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Kanghua Healthcare Group Co Marketable Securities Chart

Guangdong Kanghua Healthcare Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.06 66.35 53.09 57.16 61.77

Guangdong Kanghua Healthcare Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.09 55.08 57.16 52.18 61.77
FRA:E9Q
82GF Score
Guangdong Kanghua Healthcare Group Co Ltd FRA:E9Q
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangdong Kanghua Healthcare Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €61.8 Mil mean?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a Marketable Securities of €61.8 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors.
Is Guangdong Kanghua Healthcare Group Co's Marketable Securities too high?
Guangdong Kanghua Healthcare Group Co's current Marketable Securities is €61.8 Mil. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's Marketable Securities compare to HCA and THC?
Guangdong Kanghua Healthcare Group Co's Marketable Securities of €61.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. Guangdong Kanghua Healthcare Group Co's current Marketable Securities is €61.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current Marketable Securities of €61.8 Mil. The stock's GF Value™ is €0.20, compared to a current price of €0.17 — trading 14% below its estimated fair value. The current Marketable Securities is €61.8 Mil. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current Marketable Securities is €61.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?

Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued. The current stock price of €0.17 is trading 14% below its estimated GF Value™ of €0.20.

Key valuation signals for FRA:E9Q:

  • Marketable Securities: €61.8 Mil
  • GF Value™: €0.20 vs. price of €0.17 (14% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangdong Kanghua Healthcare Group Co Business Description

Other Exchanges 03689:Hong Kong
Address 1000 Dongguan Avenue, Guangdong Province, Dongguan, CHN
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
82GF Score

Get the complete analysis for FRA:E9Q

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.17
Price
€0.20
GF Value